Idexx Laboratories Inc /DE SEC filings IDXX
Idexx Laboratories Inc /DE has 1,005 filings in SEC EDGAR's recent list, going back to Feb 9, 2015. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 144/A | Filing | Nov 5, 2026 | — |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| 10-Q | Quarterly report | Nov 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 30, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 4 | Insider transaction | Aug 24, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | Jun 1, 2026 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 15, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 4, 2026 | Apr 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2026 | — |
| ARS | Annual report to shareholders | Mar 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| DEF 14A | Proxy statement | Mar 27, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2026 | Mar 24, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 13, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4/A | Form 4/a | Mar 3, 2026 | Feb 12, 2026 |
| 144 | Notice of proposed sale | Mar 3, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 144 | Notice of proposed sale | Feb 26, 2026 | — |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| 10-K | Annual report | Feb 20, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 12, 2026 |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 144 | Notice of proposed sale | Feb 10, 2026 | — |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 13, 2026 | Jan 11, 2026 |
| 4 | Insider transaction | Dec 3, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 13, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 10, 2025 | Nov 7, 2025 |
| 144 | Notice of proposed sale | Nov 7, 2025 | — |
| 4 | Insider transaction | Nov 3, 2025 | Oct 30, 2025 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 3/A | Form 3/a | Oct 20, 2025 | Oct 6, 2025 |
| 3 | Initial insider ownership | Oct 14, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Sep 4, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 1, 2025 |
| 4 | Insider transaction | Sep 3, 2025 | Sep 1, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 5/A | Form 5/a | Aug 14, 2025 | Dec 31, 2024 |
| 3/A | Form 3/a | Aug 14, 2025 | Jan 1, 2024 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 7, 2025 |
| 144 | Notice of proposed sale | Aug 11, 2025 | — |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 6, 2025 |
| 144 | Notice of proposed sale | Aug 8, 2025 | — |
| 144 | Notice of proposed sale | Aug 6, 2025 | — |
| 144 | Notice of proposed sale | Aug 6, 2025 | — |
| 144 | Notice of proposed sale | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2025 | Aug 4, 2025 |
| 3 | Initial insider ownership | Jul 18, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2025 | Jul 10, 2025 |
| UPLOAD | Letter from the SEC | Jul 7, 2025 | — |
| 4 | Insider transaction | Jun 3, 2025 | Jun 1, 2025 |
| CORRESP | Letter to the SEC | Jun 2, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| 4 | Insider transaction | May 14, 2025 | May 13, 2025 |
| 144 | Notice of proposed sale | May 13, 2025 | — |
| 4 | Insider transaction | May 13, 2025 | May 9, 2025 |
| 144 | Notice of proposed sale | May 9, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 7, 2025 |
| 144 | Notice of proposed sale | May 2, 2025 | — |
| 10-Q | Quarterly report | May 1, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| ARS | Annual report to shareholders | Mar 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 28, 2025 | — |
| DEF 14A | Proxy statement | Mar 28, 2025 | Dec 31, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2025 | Dec 31, 2024 |
| 3 | Initial insider ownership | Mar 10, 2025 | Mar 1, 2025 |
| 10-K | Annual report | Feb 21, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 18, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2025 | Feb 13, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 11, 2025 |
| 4 | Insider transaction | Feb 11, 2025 | Feb 7, 2025 |
| 144 | Notice of proposed sale | Feb 10, 2025 | — |
| 4 | Insider transaction | Feb 10, 2025 | Feb 7, 2025 |
| 144 | Notice of proposed sale | Feb 7, 2025 | — |
| 8-K |
Current report
Results of operations
|
Feb 3, 2025 | Feb 3, 2025 |
| 5 | Annual insider ownership | Jan 21, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 12, 2024 | Dec 6, 2024 |
| 8-K |
Current report
Other events
|
Dec 9, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Nov 29, 2024 | Nov 27, 2024 |
| 144 | Notice of proposed sale | Nov 27, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 21, 2024 | Nov 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 6, 2024 | Oct 31, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K/A |
Amended current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 4 | Insider transaction | Sep 9, 2024 | Sep 6, 2024 |
| 4 | Insider transaction | Sep 9, 2024 | Sep 5, 2024 |
| 144 | Notice of proposed sale | Sep 6, 2024 | — |
| 4 | Insider transaction | Sep 4, 2024 | Sep 1, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Sep 1, 2024 |
| 4 | Insider transaction | Aug 7, 2024 | Aug 5, 2024 |
| 4 | Insider transaction | Aug 7, 2024 | Aug 5, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 17, 2024 |
| 144 | Notice of proposed sale | May 17, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 10, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 4 | Insider transaction | May 8, 2024 | May 6, 2024 |
| 10-Q | Quarterly report | May 1, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 1, 2024 | May 1, 2024 |
| ARS | Annual report to shareholders | Mar 27, 2024 | Dec 31, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- IDXX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westbrook, ME
- SEC filer status
- Large accelerated filer
- SEC CIK
- 874716
Other In Vitro & In Vivo Diagnostic Substances companies
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.